• 0 Posts
  • 11 Comments
Joined 1 year ago
cake
Cake day: January 24th, 2024

help-circle


  • Looking at a couple publications from the lab funding appears to be from a couple different foundations but nothing commercial. Pharma barely puts anything into basic R+D unless they’re a startup. Established pharma R+D is largely clinical trials and/or process development. If her work is patented by the university then pharma may pay the university to use her work. University would then give a smaller kickback to the lab/scientists.

    NCI (national cancer institute-part of NIH) was the largest cancer research funder in the US, about 7B worth and even then less than 10% of proposed projects were being funded. The ACS (American cancer society) funds about 100M.